Preparing for the Class XII Economics board examination requires a clear strategy, regular practice and strong conceptual ...

PSQ Holdings, Inc. (NYSE: PSQH) (the "Company"), a payments and financial infrastructure company, today reported financial ...

The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31 ...

The Beauty Health Company (NASDAQ:SKIN) Q4 2025 Earnings Call Transcript March 12, 2026 The Beauty Health Company misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were ...

The Beauty Health Company (NASDAQ: SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results ...

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

NatGold Digital Ltd. ("NatGold" or the "Company") today announced that it has signed a Definitive Agreement with Sovereon Gold Corp. granting NatGold the exclusive right to acquire a 100% undivided ...

Noel Parks - Tuohy Brothers Investment Research, Inc. Siddharth Rajeev - Fundamental Research Corp. Greetings, and welcome to the Energy Vault's Fourth Quarter 2025 Earnings Call. [Operator ...

Discretionary assets under management (“AUM”), which primarily drives the firm’s revenue, decreased 1.2% during the fourth quarter, from $24.3 billion to $24.0 billion. For the year 2025, total ...

"Securing the option on the Friday Gold Project represents an important expansion of the supply side of the NatGold Digital Mining Ecosystem at a time when the Company is entering the final stages of ...

Bourse drops as Iraq tanker attack and Omani port threat spark oil surge; ANZ and CBA tip March rate rise; UBS upgrades aluminium, coal forecasts; IperionX losses widen. Follow live.

For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of FDA-approved C3 inhibitors that targets the root of the complement system can ...